Selank Research Guide (2026): What It Is, Where to Source It

Selank is a synthetic heptapeptide that emerged from Russian neuropeptide research in the 1990s. Unlike most peptides on the US research market, which trace back to Western pharmaceutical or academic labs, Selank's origin story sits squarely in the Soviet and post-Soviet research tradition. This guide covers what the compound is, what the literature has examined, and what to look for when sourcing it for laboratory research.

Important framing: Selank is not FDA-approved and is not intended for human use. All references to "effects" in this article refer to findings in animal models or published preclinical research. This article is for research-use education only.

The origin — a Russian neuropeptide

Selank was developed by the Institute of Molecular Genetics of the Russian Academy of Sciences, in collaboration with the V.V. Zakusov Institute of Pharmacology. It was designed as a synthetic analog of tuftsin, a naturally occurring tetrapeptide fragment of the immunoglobulin G heavy chain that has been studied for its immunomodulatory activity.

The Russian research program around Selank focused on extending tuftsin's half-life. Native tuftsin is rapidly degraded by peptidases in plasma. By adding a stabilizing Pro-Gly-Pro tripeptide tail, Russian chemists produced a peptide with substantially longer in vivo stability, which made it viable as a research compound for sustained-dose studies.

In Russia, Selank received regulatory approval as a prescription anxiolytic medication. In the US and most Western markets, it has not been approved for any human indication and is available only as a research compound.

The structure

Selank is a 7-amino-acid peptide with the sequence:

Thr-Lys-Pro-Arg-Pro-Gly-Pro

The first four residues (Thr-Lys-Pro-Arg) are the tuftsin sequence. The trailing Pro-Gly-Pro is the stabilizing extension that distinguishes Selank from native tuftsin.

Property	Value
Sequence	Thr-Lys-Pro-Arg-Pro-Gly-Pro
Molecular formula	C₃₃H₅₇N₁₁O₉
Molecular weight	751.88 g/mol
Class	Synthetic heptapeptide, tuftsin analog
Origin	Institute of Molecular Genetics, Russia

What the research has examined

Most published Selank research is in Russian-language journals, which limits accessibility for Western researchers. The English-language literature is comparatively thin but covers several investigation areas in animal models:

• Anxiolytic models — rodent studies examining behavior in elevated plus maze, open field, and conflict tests
• Cognitive function models — passive avoidance and active learning tasks in rats
• Anti-stress models — physiological and behavioral responses to acute stressors
• Neurotransmitter modulation — effects on GABA, serotonin, and BDNF expression in rat brain tissue
• Immunomodulation — carryover from the tuftsin parent compound, examining cytokine and interferon expression

A handful of small Russian clinical studies have been published, but the compound has not undergone rigorous Western clinical trials. As with most niche neuropeptides, the gap between "studied in rats" and "established in humans" is wide.

The sourcing landscape

This is where Selank diverges from more mainstream research peptides like BPC-157 or semaglutide. Because Selank is a niche compound, the US supplier landscape is comparatively narrow:

• Specialty research peptide suppliers carry it, often as a secondary listing alongside their main catalog of GLP-1 analogs and tissue-repair peptides.
• Generic research chemical sites sometimes list it, with widely varying quality.
• Direct-from-Russia sources exist but carry import, documentation, and chain-of-custody complications.

In our 2026 supplier review work, we identified a small number of US-based suppliers that carry Selank with batch-specific HPLC documentation. The list is meaningfully shorter than for BPC-157.

Sourcing channel	Typical purity	Documentation	Cold-chain
Specialty US research suppliers	97-99%	Batch COA available	Usually yes
Generic research chemical sites	Varies widely	Generic or absent	Rare
Direct-from-Russia	Varies	Russian-language COA	Inconsistent

Quality markers to look for

The quality markers for Selank are the same as for any research peptide, with one wrinkle: because Selank is niche, fewer suppliers have invested in serious QC for it.

HPLC purity ≥97%

The minimum acceptable purity for research use. For neuropeptide research where downstream effects are subtle, even small purity gaps can introduce noise into experimental results. Look for a published chromatogram with a single dominant peak.

Batch-specific Certificate of Analysis

Generic COAs are common in the niche-peptide segment because suppliers don't run fresh HPLC on every batch. The COA you receive should reference the exact lot number on your vial and be dated within a few months of your order.

Cold-chain shipping

Selank is reasonably stable in lyophilized form, but reconstituted Selank degrades faster than many peptides because of the exposed N-terminal threonine. Cold-chain shipping matters — especially in summer.

Vial integrity

Sealed vial, no visible discoloration, lyophilized cake intact. The cake should look uniform and dry.

A supplier that actually knows the compound

A serious research supplier carrying Selank should be able to answer basic questions about storage, reconstitution, and the published purity. If customer support doesn't know what Selank is, that's a signal about how the compound is handled internally.

Pricing

Because Selank is a niche compound, prices vary more widely than for mainstream peptides. The synthesis cost is real — a 7-amino-acid peptide isn't trivial to make at high purity — but the smaller market means each supplier sets pricing somewhat independently.

Typical 2026 US market pricing for research-grade Selank, 5mg vial:

Tier	Price range (5mg vial)	Notes
Premium US research suppliers	$40-65	Batch COA, cold-chain
Mid-market	$25-40	Generic COA, mixed shipping
Bargain / suspect	under $20	Unverified purity, no real QC

The very low-priced listings should be approached with skepticism. Selank synthesis is non-trivial and the cost floor is real. Pricing well below market median usually means corners cut on purity, testing, or both.

Administration in research models

Most published Selank research has used intranasal administration, which makes sense for a neuropeptide targeting central nervous system pathways — intranasal delivery offers a route into the CNS that bypasses first-pass metabolism.

• Intranasal — the most common research route, used in most rat behavioral studies
• Sublingual — sometimes used in research models because the peptide is relatively stable in solution
• Subcutaneous / IP injection — used in some preclinical work, particularly mechanism studies

For reconstitution, Selank is typically dissolved in bacteriostatic water or sterile saline. Once reconstituted, refrigerated storage (2-8°C) is standard, with use within 30 days. Beyond 30 days, stability is poorly characterized in published literature.

Storage

Storage practices for research-grade Selank:

• Lyophilized vials — refrigerated (2-8°C), away from light, in original packaging. Stable for 12-24 months.
• Reconstituted solution — refrigerated, used within 30 days.
• Frozen aliquots — for longer-term storage of reconstituted material, frozen at -20°C. Avoid repeated freeze-thaw cycles.

Suppliers that ship without temperature control are a particular concern for Selank because the niche-peptide segment has weaker QC norms overall.

What to avoid

Generic COAs

A COA that doesn't match the batch on your vial is essentially decorative. This is more common with niche compounds because some suppliers reuse a single document across batches.

Unrealistic pricing

A 5mg vial priced under $20 from an unknown source is a red flag. Selank's synthesis cost rules out genuine premium product at that price point.

Suppliers that don't list a COA at all

For a niche compound where buyer awareness is lower, some sellers skip COAs entirely. Walk away.

Russian-language documentation you can't verify

A Russian-language COA isn't automatically bad, but if you can't read it and you can't independently verify the testing lab, it's effectively no documentation at all.

Bottom line

Selank is a niche research compound with an unusual origin — a Russian neuropeptide built as a stabilized tuftsin analog, studied primarily in Russian-language anxiolytic and cognitive research literature. For US researchers, the sourcing landscape is narrower than for mainstream peptides, and supplier quality varies more.

Look for ≥97% HPLC-verified purity, batch-specific COAs, and cold-chain shipping. The premium-tier US suppliers that carry Selank are the safest starting point.

Our recommended US supplier for Selank research is ROEHN Research, which carries the compound with batch-specific testing and standard cold-chain shipping.

2026 Evaluation

9.6/10

Top-Ranked 2026 Supplier

The top-ranked supplier in our 2026 evaluation

ROEHN Research tested at 99.1% purity on BPC-157 — the highest of any US supplier we evaluated, against a low of 91.3%. Readers save 15% on a first order with code FREE15.

View ROEHN Research→

Save 15% with code FREE15

• Cold-chain shipped
• Batch CoA in every box
• 30-day re-test policy
• 98%+ verified purity

---

Important: All products referenced are intended for laboratory research use only. They are not for human consumption, not intended to diagnose, treat, cure, or prevent any disease, and are not FDA-approved for human use. Read our methodology and about page for details on our testing and editorial policies.